Thursday, 17 November 2011 12:56


Written by Law Offices Of Gary Green

Actos (pioglitazone) is manufactured by Takeda Pharmaceuticals and is a drug normally prescribed for the treatment of Type II diabetes. On June 16, 2011, the FDA issued a new warning citing increased risk of bladder cancer in patients taking Actos for more than a year. In September, 2011 the FDA began a safety review of Actos after initial data from the manufacturer’s ongoing study indicated that the drug may increase the risk of bladder cancer. Two European countries have already banned the use of the drug. However, the FDA has not banned these medicines from being issued in the United States.

If you or someone you know suffered from bladder cancer while using Actos, contact Law Offices of Gary Green toll free at 1-888-4GARYGREEN or send us an e-mail at